Early price setting is key for emerging drug, device companies - STAT

Early price setting is key for emerging drug, device companies - STAT

STAT Plus: Early price setting, other market access planning is key for early-stage drug, device companies

By CHRISTOPHER LEO AND CHRISTIAN THIENEL AND BRENDAN WANG

ADOBE

Price setting and other market access planning should be the focus for emerging drug and device companies at ever-earlier stages of development.

READ MORE